Deals Shaping The Medical Industry, November 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2016.

Oxford Immunotec Global PLC is paying $6mm in cash to acquire Immunetics Inc. (immunoassays for infectious diseases). Oxford could also shell out up to $6mm in cash upon attaining certain revenue goals and development milestones over the next three years. (Oct.)

Immunetics offers rapid, cost-effective ELISA and Western Blot tests that are highly specific and sensitive. Its BacTx is a colorimetric assay kit that can detect aerobic, anaerobic, gram-negative, and gram-positive bacteria in a single test. The QuickELISA kit is designed to detect antibodies to protective antigen of anthrax in human serum. Finally, the C6 B. burgdorferi (Lyme) ELISA kit delivers faster and more accurate results than any other ELISA and is twice as sensitive than the standard Western Blot in patients with Lyme disease

More from Deal-Making

More from In Vivo